PKCδ Knockout Mice Are Protected from Dextromethorphan-Induced Serotonergic Behaviors in Mice: Involvements of Downregulation of 5-HT1A Receptor and Upregulation of Nrf2-Dependent GSH Synthesis

Mol Neurobiol. 2018 Oct;55(10):7802-7821. doi: 10.1007/s12035-018-0938-7. Epub 2018 Feb 22.

Abstract

We investigated whether a specific serotonin (5-HT) receptor-mediated mechanism was involved in dextromethorphan (DM)-induced serotonergic behaviors. We firstly observed that the activation of 5-HT1A receptor, but not 5-HT2A receptor, contributed to DM-induced serotonergic behaviors in mice. We aimed to determine whether the upregulation of 5-HT1A receptor induced by DM facilitates the specific induction of certain PKC isoform, because previous reports suggested that 5-HT1A receptor activates protein kinase C (PKC). A high dose of DM (80 mg/kg, i.p.) induced a selective induction of PKCδ out of PKCα, PKCβI, PKCβII, PKCξ, and PKCδ in the hypothalamus of wild-type (WT) mice. More importantly, 5-HT1A receptor co-immunoprecipitated PKCδ in the presence of DM. Consistently, rottlerin, a pharmacological inhibitor of PKCδ, or PKCδ knockout significantly protected against increases in 5-HT1A receptor gene expression, 5-HT turnover rate, and serotonergic behaviors induced by DM. Treatment with DM resulted in an initial increase in nuclear factor erythroid-2-related factor 2 (Nrf2) nuclear translocation and DNA-binding activity, γ-glutamylcysteine (GCL) mRNA expression, and glutathione (GSH) level. This compensative induction was further potentiated by rottlerin or PKCδ knockout. However, GCL mRNA and GSH/GSSG levels were decreased 6 and 12 h post-DM. These decreases were attenuated by PKCδ inhibition. Our results suggest that interaction between 5-HT1A receptor and PKCδ is critical for inducing DM-induced serotonergic behaviors and that inhibition of PKCδ attenuates the serotonergic behaviors via downregulation of 5-HT1A receptor and upregulation of Nrf2-dependent GSH synthesis.

Keywords: 5-HT1A receptor; Dextromethorphan; Hypothalamus; Nuclear factor erythroid-2-related factor 2; Protein kinase C δ knockout mice; Serotonin syndrome.

MeSH terms

  • Acetophenones / pharmacology
  • Animals
  • Behavior, Animal*
  • Benzopyrans / pharmacology
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Dextromethorphan
  • Down-Regulation*
  • Glutamate-Cysteine Ligase / genetics
  • Glutamate-Cysteine Ligase / metabolism
  • Glutathione / biosynthesis*
  • Glutathione Disulfide / metabolism
  • Hypothalamus / metabolism
  • Hypothermia, Induced
  • Isoenzymes / metabolism
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NF-E2-Related Factor 2 / metabolism*
  • Neuroprotective Agents / pharmacology
  • Phosphorylation / drug effects
  • Piperazines / pharmacology
  • Protein Kinase C-delta / metabolism*
  • Pyridines / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptor, Serotonin, 5-HT1A / metabolism*
  • Receptor, Serotonin, 5-HT2A / metabolism
  • Serotonin / metabolism*
  • Serotonin 5-HT1 Receptor Antagonists / pharmacology
  • Time Factors
  • Up-Regulation*

Substances

  • Acetophenones
  • Benzopyrans
  • Isoenzymes
  • NF-E2-Related Factor 2
  • Neuroprotective Agents
  • Piperazines
  • Pyridines
  • RNA, Messenger
  • Receptor, Serotonin, 5-HT2A
  • Serotonin 5-HT1 Receptor Antagonists
  • Receptor, Serotonin, 5-HT1A
  • Serotonin
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
  • Dextromethorphan
  • rottlerin
  • Protein Kinase C-delta
  • Glutamate-Cysteine Ligase
  • Glutathione
  • Glutathione Disulfide